Stock info MDxHealth | Filter Basic-Info
Stock: MDxHealth (Bel small), ISIN: BE0003844611
| Last Price | 3.02 | Max Price | 3.09 |
| Min Price | 2.90 | 1 Year return | 403.33 |
| Avg. Target | 0.00 | Expected Return | -100.00 % |
| Sector | Health Care | Subsector | Biotechnology |
| Sell | 0 | Rating | |
| Hold | 0 | Concensus | |
| Buy | 0 | ||
| Annual report 2018 |
OncoMethylome Sciences is a molecular diagnostics company developing gene methylation tests for early cancer detection and personalized treatment decisions. OncoMethylome Sciences was founded in 2003 and is headquartered in Belgium. Its offices and laboratories are located in Belgium, the Netherlands and the USA (Durham, NC). OncoMethylome Sciences’ stocks are traded on the Euronext Amsterdam and the company is a component of the Local Securities-index (ISIN: BE0003844611/ Mnemo: ONCOA).
Contact info:Zip Code: 4000 LiegeCity: LiegeCountry: BelgiumPhone: 32 (0) 4 364 20Email: ir@mdxhealth.comWebsite: www.mdxhealth.com
Sector Review MDxHealth
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 12 | 141,925 | 0.01 % |
| 2020 | 18 | 170,231 | 0.01 % |
| 2021 | 22 | 252,886 | 0.01 % |
| 2022 | 37 | 238,496 | 0.02 % |
| 2023 | 0 | 0 | 0.00 % |
Advice MDxHealth
News MDxHealth
Past years share MDxHealth huge underperformer
Annual reports MDxHealth
| 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
Profile MDxHealth
MDxHealth
(BE0003844611)/ MDXHThe past year was a good year for MDxHealth investors
The stock gained over the past 12 months at around 26 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 215 percent. MDxHealth's revenues between 2011 and 2015 were far from constant and moved between 4,48 million euros and 16,24 million euros. MDxHealth's net results between 2011 and 2015 were far from constant and moved between -7,46 million euros and 0 million euros.
The headquarter of MDxHealth is located in Liege. MDxHealth primarily operates in the biotech sector. The global biotech companies gained around 59 percent over the period 2006-2016. Measured since 2011 the sector is 70 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 59 percent.
The Belgian company didn't pay out any dividends (in the past 5 years).
At the end of 2015 around 84 people were employed at MDxHealth.
MDxHealth financed with relatively low debt
As per the end of 2015 the Belgian company's balance sheet equaled 0 million euros. The total debt of the biotech company was at the end of 2015 0 million euros, which equals around percent of the total balance sheet.
At the end of 2015 the biotech company's market size (her number of outstanding share times the stock price) equaled around 183,32 million euros. At the end of 2015 around 45,15 million stocks were listed.
All the company's financial reports are available here. More information about MDxHealth can be found it's website. .
Results MDxHealth
| Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Revenue |
18
|
30
|
41
|
28
|
12
|
18
|
| Costs |
32
|
43
|
53
|
61
|
55
|
47
|
| Profit |
-14
|
-13
|
-12
|
-32
|
-43
|
-29
|
| Margin of profit |
-82.03
|
-43.94
|
-30.34
|
-114.26
|
-365.56
|
-155.25
|
| ROI |
-32.69
|
-24.97
|
-28.22
|
-62.26
|
-218.56
|
-489.91
|
Balance MDxHealth
| Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Equity |
44
|
53
|
44
|
52
|
20
|
6
|
| Debt |
13
|
15
|
15
|
13
|
21
|
26
|
| Total assets |
58
|
68
|
59
|
65
|
41
|
32
|
| Solvency |
76.65
|
77.88
|
74.42
|
79.60
|
48.54
|
18.36
|
| Cash |
32
|
31
|
17
|
26
|
22
|
16
|
| Cashflow |
-14
|
-17
|
-10
|
-29
|
-22
|
-20
|
| Employees |
95
|
162
|
232
|
187
|
0
|
|
| Revenue per employee |
0.19
|
0.18
|
0.17
|
0.15
|
0.0
|
|
| Cashflow / Debt |
-1.07
|
-1.11
|
-0.70
|
-2.14
|
-1.07
|
-0.78
|
Details MDxHealth
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
4.12
|
4.79
|
3.21
|
1.85
|
1.04
|
| Eps |
-0.29
|
-0.25
|
-0.56
|
-0.69
|
-0.34
|
| Price/earnings-ratio |
-14.21
|
-19.16
|
-5.73
|
-2.68
|
-8.88
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
1.06
|
0.87
|
0.87
|
0.28
|
0.06
|
| Market to book |
0.26
|
0.18
|
0.27
|
0.15
|
0.02
|
| Cashflow per stock |
-0.33
|
-0.21
|
-0.48
|
-0.32
|
-0.22
|
| Stocks |
50
|
50
|
60
|
71
|
91
|
| Market Cap |
205.36
|
239.26
|
192.41
|
130.48
|
273.89
|
Dividend MDxHealth
Price info MDxHealth
|
Date
|
Price
|
|---|---|
|
13 Nov 2024
|
3.02
|
|
08 Nov 2024
|
3.02
|
|
05 Nov 2024
|
3.02
|
|
31 Oct 2024
|
3.02
|
|
29 Oct 2024
|
3.02
|
|
23 Oct 2024
|
3.02
|
|
19 Oct 2024
|
3.02
|
|
16 Oct 2024
|
3.02
|
|
14 Oct 2024
|
3.02
|
|
05 Oct 2024
|
3.02
|
|
02 Oct 2024
|
3.02
|
|
27 Sep 2024
|
3.02
|
|
20 Sep 2024
|
3.02
|
|
17 Sep 2024
|
3.02
|
|
13 Sep 2024
|
3.02
|
|
28 Aug 2024
|
3.02
|
|
26 Aug 2024
|
3.02
|
|
23 Aug 2024
|
3.02
|
|
11 Aug 2024
|
3.02
|
|
07 Aug 2024
|
3.02
|
|
05 Aug 2024
|
3.02
|
|
01 Aug 2024
|
3.02
|
|
30 Jul 2024
|
3.02
|
|
26 Jul 2024
|
3.02
|
|
23 Jul 2024
|
3.02
|
|
16 Jul 2024
|
3.02
|
|
10 Jul 2024
|
3.02
|
|
09 Jul 2024
|
3.02
|
|
04 Jul 2024
|
3.02
|
|
02 Jul 2024
|
3.02
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
